Página PrincipalSobre Merck SeronoContactarGlosarioReferenciasBúsquedaContenidos

Inquietudes MenuInquietudes
Tratamiento MenuTratamiento
Embarazo MenuEmbarazo
Experiencias MenuExperiencias

Referencias

Referencias
 
Lecturas adicionales para ampliar la información de este sitio

A continuación le presentamos las referencias bibliográficas que fueron utilizadas para crear todo el contenido del sitio. Si a usted le interesa obtener información más detallada sobre el tema de fertilidad, por favor consulte los siguientes documentos y trabajos.
  1. ICSI LogoFor more information on coping with infertility, patient associations such as ICSI are a good resource..

  2. Hillier SG.. Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis.. Hum Reprod. 1994 Feb. 9(2):188-91.

  3. The European Recombinant Human LH Study Group. Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. J Clin Endocrinol Metab. 1998 May. 83(5):1507-14.

  4. Giudice E, Crisci C, Altarocca V, O'Brien M. Journal of Clinical Research. 2001. 4:27-34.

  5. Olivennes F, Belaisch-Allart J, Emperaire J-C et al. Prospective randomized, controlled study of in vitro fertilisation-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LHRH) antagonist (cetrorelix) or a depot formula of an LHRH agonist (triptorelin). Fertil Steril. 2000. 73(2):314-20.

  6. Albano C, Felberbaum RE, Smitz J et al. Ovarian stimulation with hMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. Hum Reprod. 2000. 15(3):526-31.

  7. Driscoll GL, Tyler JPP, Hangen JT et al. A prospective, randomised, controlled, double blind, double dummy comparison of recombinant and urinary hCG for inducing oocyte maturation and follicular luteinization in controlled ovarian hyperstimulation. Hum Reprod. 2000. 15 (6):1305 - 1310.

  8. International r-hCG Study Group. Induction of ovulation in World Health Organization group II anovulatory women undergoing follicular stimulation with recombinant human follicle stimulating hormone: a comparison of recombinant-human chorionic gonadotropin (r-hCG) and urinary-hCG. Fertility and Sterility, Vo. 75, no. 6. June 2001. pp. 1111-1118.

  9. The European Recombinant Human Chorionic Gonadotropin Study Group. Induction of final follicular maturation and early luteinisation in women undergoing ovulation induction for assisted reproductive treatment - recombinant hCG versus urinary hCG. Hum Reprod. 2000. 15 (7): 1446 - 1451.

  10. Cicinelli E, de Ziegler D, Bulleti C, et al. Direct transport of progesterone from the vagina to the uterus. Obstet Gynecol. 2000. 95:403-406.

  11. Fanchin R, de Ziegler D, Bergeron C, et al. Transvaginal administration of progesterone. Obstet Gynecol. 1997. 90:396-401.

  12. Bulletti C, de Ziegler D, Bergeron C, et al. Targeted drug delivery in gynaecology: the first uterine pass effect. Hum Reprod. 1997. 12:1073-1079.

  13. Fanchin R, Righini C, de Ziegler D, Olivennes F, Ledee N, Frydman R. Effects of vaginal progesterone administration on uterine contractility at the time of embryo transfer. Fertil Steril. 2001 Jun. 75(6):1136-40.

  14. Guidice E, Crisci C, Altarocca V, O'Brien, M. Characterization of a partilally purified human menopausal gonadatropin preparation. Journal of Clinical Research. 2001. 4 : 27-34.

  15. Le Cotonnec JY, Porchet HC, Beltrami V, Munafo A.. Clinical pharmacology of recombinant human luteinizing hormone: Part 1. Pharmacokinetics after intravenous administration to healthy female volunteers and comparison with urinary human luteinizing hormone. Fertil Steril. 1998c. 69: 201-9.

  16. Ludwig M, Katalinic A, Diedrich K. Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocol. Arch Gynecol Obstet. (2001). 265:175-182.

  17. Albano et al. Human Rep Vol. 15. No 3. 2000. pp. 526-531.

  18. Keck et al. Geburtsh Fraueheilk. 2000. 60: 212-217.

  19. Gibbons WE et al. Fertility and Sterility. 1998. 69: 96-101.

  20. Schoolcraft WB, Hesla JS, Gee M et al. In a highly successful IVF program, progesterone administered from single daily IM injections or vaginal progesterone gel applications is equally effective at providing luteal support. Poster presented at the 55th Annual Meeting of the American Society for Reproductive Medicine. September 25-30, 1999; Toronto. Canada. Abstract.

  21. Keefe D. Interim results presented at the 55th Annual Meeting of the American Society for Reproductive Medicine. September 25-30, 1999, Toronto, Canada.

  22. "What are the risk factors for female infertility?". UC Davis Health System, Health and Wellness.
    http://www.ucdmc.ucdavis.edu/ucdhs/
    health/a-z/22InfertilityWomen/doc22risks.html    .

  23. "What are the lifestyle measures for female infertility?". UC Davis Health System, Heath and Wellness.
    http://www.ucdmc.ucdavis.edu/
    ucdhs/health/a-z/22InfertilityWomen/doc22lifestyle.html    .

  24. "Optimize your fertility". RESOLVE: The National Infertility Association.
    http://www.resolve.org/main/national/
    trying/optimize/index.jsp?name=trying&tag=optimize    .

  25. "Caffeine,". The Center for the Evaluation of Risks to Human Reproduction, National Institute of Environmental Health Sciences. NIH.
    http://cerhr.niehs.nih.gov/genpub/topics/caffeine-ccae.html.

  26. "Walking: A step in the right direction". NIH Publication No. 01-4155 National Institute of Diabetes and Digestive and Kidney Diseases, NIH.. March 2001.
    http://www.niddk.nih.gov/health/
    nutrit/walking/walkingbro/walking.htm    .

  27. "Energize yourself and your family". NIH Publication No. 01-4926 National Institute of Diabetes and Digestive and Kidney Diseases, NIH.. March 2001.
    http://www.niddk.nih.gov/health/
    nutrit/walking/energizeself/energizeyrslf.html    .

  28. "Frequently Asked Questions". The InterNational Council on Infertility Information Dissemination, Inc..
    http://www.inciid.org/faq/general8.html.

  29. "Relaxation and Stress Management For Infertile Women". RESOLVE.
    http://www.resolve.org/main/national/
    coping/manage/meditation.jsp?name=coping&tag=manage    .

  30. "Tai Chi". National Women's Health Resource Center.
    http://healthywomen.org/content.cfm?L1=3.

  31. "Yoga". National Women's Health Resource Center.
    http://healthywomen.org/content.cfm?L1=3&L2=94&L3=0&SS=0.

  32. "General Information". American Yoga Association.
    http://www.americanyogaassociation.org/general.html.

  33. "How Stress Affects the Body". American Medical Women's Association. Updated April 2000.
    http://www.amwa-doc.org/publications/
    WCHealthbook/stressamwa-ch09.html    .

  34. "Helping Yourself to a Good Night's Sleep,". National Sleep Foundation.
    http://www.sleepfoundation.org/publications/goodnights.html.

  35. "Fact Sheet Stress and Infertility". American Society for Reproductive Medicine.
    http://www.asrm.org/Patients/FactSheets/Stress-Fact.pdf.

  36. "Stress and Infertility" (Chapter 32) How to Have a Baby: Overcoming Infertility. Aniruddha Malpani, MD and. Anjali Malpani, MD.
    http://infertility.adoption.com/chapter32.php.




To Top Of Page
© 2008 Merck Serono España S.A. Lea nuestro Aviso Legal.
Página internacional: www.fertility.com
Ultima actualización:14/05/2008		Link to Serono Corporate Site